ROYAL BANK OF CANADA - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$264,000
-68.9%
77,787
-32.6%
0.00%
Q2 2023$849,000
+249.4%
115,355
+391.9%
0.00%
Q1 2023$243,000
+2.1%
23,451
+16.1%
0.00%
Q4 2022$238,000
+376.0%
20,201
+758.2%
0.00%
Q3 2022$50,000
-7.4%
2,354
+37.2%
0.00%
Q2 2022$54,000
-72.7%
1,716
-64.6%
0.00%
Q1 2022$198,000
-74.2%
4,842
-72.5%
0.00%
Q4 2021$767,000
-96.1%
17,627
-95.6%
0.00%
-100.0%
Q3 2021$19,868,000
-12.0%
396,817
+10.7%
0.01%
-16.7%
Q2 2021$22,583,000
-40.8%
358,526
-12.7%
0.01%
-45.5%
Q1 2021$38,151,000
+64.6%
410,614
+58.7%
0.01%
+57.1%
Q4 2020$23,176,000
-17.2%
258,673
-4.6%
0.01%
-30.0%
Q3 2020$28,005,000
-3.7%
271,042
-26.3%
0.01%
-16.7%
Q2 2020$29,077,000
+24.0%
367,681
-9.3%
0.01%
+9.1%
Q1 2020$23,447,000
+9.2%
405,244
+1.8%
0.01%
+37.5%
Q4 2019$21,467,000
-6.8%
397,900
-9.7%
0.01%
-11.1%
Q3 2019$23,026,000
-0.7%
440,453
-8.2%
0.01%0.0%
Q2 2019$23,183,000
-23.6%
479,904
-20.1%
0.01%
-30.8%
Q1 2019$30,339,000
-20.6%
600,512
-6.8%
0.01%
-27.8%
Q4 2018$38,194,000
-38.8%
644,273
-32.0%
0.02%
-30.8%
Q3 2018$62,398,000
+16.7%
947,861
-10.5%
0.03%
+8.3%
Q2 2018$53,464,000
-13.3%
1,058,920
-9.6%
0.02%
-14.3%
Q1 2018$61,669,000
+6.4%
1,171,315
-6.1%
0.03%
+12.0%
Q4 2017$57,977,000
+27.6%
1,247,629
+11.1%
0.02%
+13.6%
Q3 2017$45,422,000
+39.7%
1,122,931
+17.1%
0.02%
+29.4%
Q2 2017$32,505,000
+19.2%
958,568
+2.1%
0.02%
+13.3%
Q1 2017$27,260,000
+8.7%
938,735
+22.9%
0.02%
+7.1%
Q4 2016$25,086,000
+117.9%
763,844
+109.2%
0.01%
+133.3%
Q3 2016$11,510,000
+2504.1%
365,049
+2220.7%
0.01%
Q2 2016$442,000
-35.9%
15,730
-17.2%
0.00%
Q1 2016$690,000
-41.9%
18,991
-36.0%
0.00%
-100.0%
Q4 2015$1,188,000
+835.4%
29,672
+569.8%
0.00%
Q3 2015$127,000
+9.5%
4,430
+26.6%
0.00%
Q2 2015$116,000
-75.4%
3,498
-78.7%
0.00%
Q1 2015$472,000
+5.1%
16,400
-0.7%
0.00%
Q4 2014$449,000
+27.6%
16,509
-0.0%
0.00%
Q3 2014$352,000
-21.3%
16,512
-16.9%
0.00%
Q2 2014$447,000
-2.0%
19,875
+10.1%
0.00%
Q1 2014$456,000
-70.1%
18,056
-72.8%
0.00%
-100.0%
Q4 2013$1,526,000
+238.4%
66,356
+180.6%
0.00%
Q3 2013$451,000
+48.8%
23,650
+12.4%
0.00%
Q2 2013$303,00021,0410.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders